Velafermin

N/A

Report date: 2022/05/17 11:54:24

Base Information

Drug NameVelafermin
Drug Alias NamerhFGF-20Fibroblast growth factor-20FGF 20Velafermin (CuraGen Corporation)CG-53135
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsStomatitisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCuragen Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuragen Corporation
Active IndicationsN/A
Inactive IndicationsStomatitisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A